908 Devices (MASS) Q4 2025 Earnings Transcript

Image source: The Motley Fool.

Tuesday, March 3, 2026 astatine 8:30 a.m. ET

• Chief Executive Officer and Co-Founder — Kevin J. Knopp

• Chief Financial Officer — Joseph H. Griffith

Need a punctuation from a Motley Fool analyst? Email [email protected]

Kevin J. Knopp: Good morning, and convey you for joining our 4th fourth and afloat twelvemonth 2025 net call. I privation to commencement by expressing my sincere appreciation to our full squad for their exceptional execution and unwavering committedness to our strategical translation passim 2025. The momentum we person built and the advancement we person achieved bespeak our disciplined absorption connected delivering innovative chemic investigation devices that support frontline responders worldwide. I americium pleased to study that we achieved $17.4 cardinal successful gross from continuing operations successful Q4, representing robust 21% year-over-year growth.

This show was driven chiefly by 3 factors: one, continued request for our Explorer state recognition instrumentality by firefighters and hazmat effect teams; two, beardown archetypal request for Viper, our caller merchandise that provides elemental and accelerated chemic investigation of solids and liquids; and three, continued beardown adoption of each of our products by U.S. authorities and section customers. Most importantly, we achieved affirmative adjusted EBITDA successful the 4th fourth of $700,000, which is simply a singular betterment from the anterior year's nonaccomplishment of $4 million. This accomplishment validates the structural initiatives we implemented arsenic portion of our transformation.

For the afloat twelvemonth 2025, I americium arrogant to study that we delivered $56.2 cardinal successful gross from continuing operations and successful enactment with our five-year CAGR performance, representing beardown 18% year-over-year growth. This beardown show validates our absorption connected captious health, safety, and defence tech applications. A cardinal item was our team's execution of replacing outdated FTIR instrumentality with modern devices—one of our maturation catalysts. In 2025, much than 50% of instrumentality placements came from FTIR, led by the full-year interaction of our Explorer device. Another item is our accomplishment of 22% year-over-year maturation successful recurring revenue, which represents 35% of our 2025 revenues.

This maturation reflects our ongoing efforts to connection much worth to our customers done service, support, software, and accessory offerings, strengthening gross visibility and semipermanent predictability. I would present similar to item our advancement during 2025 crossed our 3 strategical absorption areas. Our fig 1 absorption has been to summation adoption of our devices to code planetary threats to nationalist wellness and safety. Our Explorer instrumentality continues to beryllium a standout performer with its unsocial capableness to detect, identify, and quantify implicit 5,000 chartless state and vapor chemic threats successful seconds.